Cargando…

1461. The Impact of Universal Varicella Vaccination on Herpes Zoster Incidence in the United States

BACKGROUND: The varicella vaccination program was implemented in the United States in 1995 and has resulted in large reductions in varicella disease burden. At the start of the varicella vaccination program, impacts on herpes zoster (HZ) epidemiology were unknown. We used a large claims database to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leung, Jessica W, Dooling, Kathleen L, Marin, Mona, Anderson, Tara C, Harpaz, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752792/ http://dx.doi.org/10.1093/ofid/ofac492.1288

Ejemplares similares

Herpes Zoster and Varicella
por: Fordyce, A. Dingwall
Publicado: (1919)

Herpes Zoster and Varicella
por: Chatterjee, Bijoy Krishna
Publicado: (1929)

2500. Incidence of Herpes Zoster in the Pre- and Post-Vaccine Era: Do Trends Differ Between Blacks And Whites?
por: Dooling, Kathleen, et al.
Publicado: (2018)

2284. Ten-Year Effectiveness of Live Virus Herpes Zoster Vaccine
por: Tseng, Hung Fu, et al.
Publicado: (2018)

801. IDSA Featured Oral Abstract: 25 Years of Varicella Vaccination Program in the United States: Health Impact during 1995–2019
por: Marin, Mona, et al.
Publicado: (2022)

2767. Variation in Incidence of Pediatric Herpes Zoster by First- and Second-Dose Varicella Vaccine Formulations
por: Weinmann, Sheila, et al.
Publicado: (2019)

The changing epidemiology of varicella and herpes zoster in Hong Kong before universal varicella vaccination in 2014
por: Chan, D. Y. W., et al.
Publicado: (2018)

Varicella Vaccination Alters the Chronological Trends of Herpes Zoster and Varicella
por: Wu, Po-Yuan, et al.
Publicado: (2013)

Risk Factors for Herpes Zoster Among Adults
por: Marin, Mona, et al.
Publicado: (2016)

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
por: Dooling, Kathleen L., et al.
Publicado: (2018)

No Consistent Evidence of Decreased Exposure to Varicella-Zoster Virus Among Older Adults in Countries with Universal Varicella Vaccination
por: Carryn, Stephane, et al.
Publicado: (2021)

Effect of universal varicella vaccination and behavioral changes against coronavirus disease 2019 pandemic on the incidence of herpes zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2021)

The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting
por: Sauboin, Christophe, et al.
Publicado: (2019)

Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data
por: Goldman, G.S., et al.
Publicado: (2013)

RELATION OF VARICELLA TO HERPES ZOSTER : I. STATISTICAL OBSERVATIONS.
por: Rivers, T. M., et al.
Publicado: (1929)

Varicella and herpes zoster vaccine development: lessons learned
por: Warren-Gash, Charlotte, et al.
Publicado: (2017)

Varicella Outbreak Surveillance in the United States, 2015–2016
por: Lopez, Adriana S, et al.
Publicado: (2017)

The positive duration of varicella zoster immunoglobulin M antibody test in herpes zoster
por: Min, Seong-Won, et al.
Publicado: (2016)

Tozinameran: Varicella zoster virus meningitis and herpes zoster infections : case report
Publicado: (2022)

Performance of Zoster Vaccine Live (Zostavax): A Systematic Review of 12 years of Experimental and Observational Evidence
por: Dooling, Kathleen, et al.
Publicado: (2017)

1629. Herpes Zoster Risk in Immunocompromised Adults in the United States: A Systematic Review
por: Dooling, Kathleen L, et al.
Publicado: (2019)

07. Recombinant Zoster Vaccine (RZV) Second-Dose Completion in Adults Age 50‒64 Years in the United States
por: Leung, Jessica, et al.
Publicado: (2021)

Closure of Varicella-Zoster Virus–Containing Vaccines Pregnancy Registry — United States, 2013
por: Marin, Mona, et al.
Publicado: (2014)

RELATION OF VARICELLA TO HERPES ZOSTER : II. CLINICAL AND EXPERIMENTAL OBSERVATIONS.
por: Rivers, T. M., et al.
Publicado: (1929)

Herpes Zoster in an Immunocompetent Child without a History of Varicella
por: Shang, Bing-Shiau, et al.
Publicado: (2021)

An adult co-presented with varicella and herpes zoster caused by varicella zoster virus genotype J, China: a case report
por: Xie, Guangcheng, et al.
Publicado: (2020)

1461. Non-Invasive Pneumococcal Pneumonia in the United States, 2013–2014
por: Matanock, Almea, et al.
Publicado: (2018)

914. Incidence of Herpes Zoster and Postherpetic Neuralgia and Herpes Zoster Vaccination in a United States Administrative Claims Database
por: Jain, Purva, et al.
Publicado: (2023)

1130 An Administrative Data-Based Study on the Association Between Psychological Stress and Herpes Zoster: Might the Conventional Wisdom Be Wrong?
por: Harpaz, Rafael, et al.
Publicado: (2014)

Incidence of Herpes Zoster and Persistent Post-Zoster Pain in Adults With or Without Diabetes in the United States
por: Suaya, Jose A., et al.
Publicado: (2014)

Severe Herpes Zoster Following Varicella Vaccination in Immunocompetent Young Children
por: Moodley, Amaran, et al.
Publicado: (2019)

Tozinameran: Herpes varicella-zoster virus infection: 2 case reports
Publicado: (2022)

Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients
por: Tayyar, Ralph, et al.
Publicado: (2023)

Update on Recommendations for Use of Herpes Zoster Vaccine
por: Hales, Craig M., et al.
Publicado: (2014)

Modeling the Impact of Exogenous Boosting and Universal Varicella Vaccination on the Clinical and Economic Burden of Varicella and Herpes Zoster in a Dynamic Population for England and Wales
por: Sharomi, Oluwaseun, et al.
Publicado: (2022)

Projected risks and health benefits of vaccination against herpes zoster and related complications in US adults
por: Janusz, Cara B., et al.
Publicado: (2022)

Recombinant varicella zoster virus glycoprotein E antigen vaccine for prevention of herpes zoster and postherpetic neuralgia
Publicado: (2021)

The Efficacy of Amenamevir for the Treatment of Disseminated Herpes Zoster Complicated with Probable Varicella-zoster Pneumonia in an Immunocompromised Patient
por: Kobayashi, Hiroki, et al.
Publicado: (2021)

2478. Impact of 20 Years of Varicella Vaccination on the Epidemiology of Herpes Zoster in the United States: An Interrupted Time Series Analysis
por: Wolfson, Lara, et al.
Publicado: (2018)

Trends in Hospitalizations With Primary Varicella and Herpes Zoster During the Prevaricella and Initial Postvaricella and Herpes Zoster Vaccine Eras, Connecticut, 1994–2012
por: Humes, Elizabeth A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fho7hqgli2lj3bl6jm9ie3goeh